GE Healthcare Advances Precision Radiation Therapy Solutions with New Products, Partners and Solutions at #ASTRO21
25 Ottobre 2021 - 8:31PM
Business Wire
At this year’s ASTRO 2021 event, GE Healthcare will showcase
over 15 innovative multi-modality radiation therapy solutions,
offering medical practitioners imaging tools and support they need
to improve patient-centered care and advance the practice of
precision medicine.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20211025005723/en/
GE Healthcare to showcase over 15
multi-modality radiation therapy solutions to improve
patient-centered care and advance precision medicine. #ASTRO21
(Photo: Business Wire)
“GE Healthcare aims to drive improved patient outcomes through
cutting-edge multi-modality radiation therapy planning and guidance
solutions. Our expertise in clinical workflows, deep learning image
reconstruction and image segmentation, and precision analytics can
help support the delivery of more efficient, precise and
personalized care," said Jan Makela, President & CEO, Imaging
at GE Healthcare.
GE Healthcare’s precision radiation oncology technologies,
including those listed below, provide clinicians with images and
information for precise tailoring of treatments.
Below are highlights that GE Healthcare will be showcasing at
ASTRO 2021 from October 24th to 27th:
- Vysioneer VBrain: GE Healthcare is proud to announce its
collaboration with Vysioneer. Vysioneer’s VBrain solution applies
auto-contouring to the three most common types of brain tumors:
brain metastasis, meningioma and acoustic neuroma. VBrain
demonstrates 12.2 percent higher sensitivity for lesion detection
while decreasing treatment planning time at a median of 30.8
percent. VBrain is vendor-neutral, integrating with different
treatment planning systems by supporting data routing to and from
DICOM nodes within a hospital network.[1]
- Spectronic Medical Synthetic CT, MR[2]
auto-segmentation: GE Healthcare will integrate Spectronic
Medical AB’s AI-based software for more precise cancer treatment
planning. This AI solution, in combination with GE Healthcare’s
advanced AIR Recon DL technology, offers a deep learning solution
and radiation therapy treatment planning alternative to standard CT
images. The combined solution begins with GE Healthcare’s AIR Recon
DL, a deep learning image reconstruction technology that leverages
raw data from the MR scanner to reduce image noise, maximize image
quality and resolution, and shorten scan times. The high-quality MR
images generated by the GE scanner are then converted into
synthetic CT images by Spectronic Medical’s AI-based solution,
providing clinicians with the CT images they have come to expect
with MR soft tissue details to more accurately target lesions and
help improve patient outcomes.[3]
- Mirada RTx[4]: As a part of their strategic
collaboration to improve outcomes for patients, GE Healthcare and
Mirada Medical are focusing on advancing automation and Artificial
Intelligence (AI) technologies to enable faster, more consistent
and more precise cancer radiotherapy treatment. To do so, the
Mirada Medical RTx product has been integrated into the GE
Healthcare AW Workstation and AW Server to enable enhanced cancer
visualization and diagnostic capabilities. These integrations
result in increased automation to deliver improvements in care
workflows and help drive efficiency and time savings.
- Discovery MI Gen 2: GE Healthcare’s Discovery MI Gen 2
brings together the high sensitivity[5] of digital detection with
the company’s industry-first CT image reconstruction technology:
Deep Learning Image Reconstruction for TrueFidelity CT Images.
Generated using a dedicated deep neural network, TrueFidelity CT
Images have the potential to improve reading confidence in a wide
range of clinical applications such as head, whole body and
cardiovascular, for patients across age groups.. The system also
offers Q.Clear for up to 2x improvement in image quality (SNR) as
well as MotionFree for up to 67 percent improvement in lesion
volume measurements[6].
- Revolution Platform: GE Healthcare's family of
intelligent CT scanners helps clinicians plan treatments to deliver
more precise and efficient RT imaging solutions. The powerful
Revolution platform is built on the wide-coverage Gemstone Clarity
detector, Deep Learning Image Reconstruction and Gemstone Spectral
Imaging to deliver superb clarity for optimizing treatment planning
and diagnostic images. It empowers clinicians to stay ahead of the
curve in an increasingly competitive market with scalable solutions
that broaden healthcare system capabilities today and
tomorrow.
- Discovery RT Gen 3: Discovery RT is a wide-bore scanner
providing a thorough approach to radiation therapy planning. In
addition to providing a streamlined workflow and sub-millimetric
images that are effectively free of motion and metal artifacts, the
system also allows for simulation across an 80 cm wide bore with 80
cm field of view reconstruction. Discovery RT expands capabilities
to also meet specific needs in diagnostic, interventional and
bariatric imaging.
Through these and a variety of additional solutions, GE
Healthcare aims to further reinforce its role as a core partner in
multidisciplinary cancer care and provide increasingly accessible,
more precise, and high-value radiation therapy.
GE Healthcare will be exhibiting at booth 1337 from October
24th to 27th.
About GE Healthcare
GE Healthcare is the $17 billion* healthcare business of GE
(NYSE: GE). As a leading global medical technology, pharmaceutical
diagnostics and digital solutions innovator, GE Healthcare enables
clinicians to make faster, more informed decisions through
intelligent devices, data analytics, applications and services,
supported by its Edison intelligence platform. With over 100 years
of healthcare industry experience and around 47,000 employees
globally, the company operates at the center of an ecosystem
working toward precision health, digitizing healthcare, helping
drive productivity and improving outcomes for patients, providers,
health systems and researchers around the world.
*Excludes Biopharma
Follow us on Facebook, LinkedIn, Twitter, and Insights for the
latest news, or visit our website www.gehealthcare.com for more
information.
[1] https://www.vysioneer.com/solution
[2] Spectronic Medical MRI Planner Software is CE marked and
510(k) pending at U.S. FDA. Not available in all markets.
[3]
https://www.ge.com/news/press-releases/ge-healthcare-to-offer-end-to-end-deep-learning-solutions-with-spectronic-medical-to
[4]
https://mirada-medical.com/product/rtx-image-registration/
[5] Discovery MI Gen 2 has the highest NEMA sensitivity in its
class in the market, compared to common PET/CT systems with the
same or similar AFOV (based on IMV’s Medical Information Division’s
2019 report as the manufacturers representing more than 90% of the
U.S. Installed Base).
[6] As demonstrated in phantom testing using a typical and fast
respiratory model and OSEM reconstruction. Quantitative accuracy
improvements are based on SUV mean.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211025005723/en/
Media Contacts Hannah Huntly London Hannah.Huntly@ge.com
+44 7887 824201
Margaret Steinhafel Chicago Margaret.Steinhafel@ge.com +1 608
381 8829
Grafico Azioni GE Aerospace (NYSE:GE)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni GE Aerospace (NYSE:GE)
Storico
Da Apr 2023 a Apr 2024